date,title,source
Oct-23-18,Clementia Announces Plan to Submit a New Drug Application for Palovarotene for the Treatment of FOP Based on Positive Phase 2 Results,GlobeNewswire
Oct-24-18,"Why Tupperware Brands, Lithia Motors, and Clementia Pharmaceuticals Jumped Today",Motley Fool
Oct-24-18,Biotech Stock Soars 35%: Clementia to File Bone Disorder NDA,Investopedia
Oct-29-18,Clementia Announces Pricing of Public Offering of Common Shares,GlobeNewswire
Oct-29-18,"DryShips, Transocean, Clementia, and More: Heres Why These Stocks Are in the Spotlight",Insider Monkey
Oct-29-18,Clementia Announces Proposed Public Offering of Common Shares,GlobeNewswire
Oct-29-18,"Consolidated Research: 2018 Summary Expectations for Insys Therapeutics, Achaogen, Astec Industries, Central European Media Enterprises, Pzena Investment Management, and Clementia Pharmaceuticals  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Nov-07-18,Clementia Reports Third Quarter 2018 Operating Results and Pipeline Updates,GlobeNewswire
Nov-21-18,Clementia to Present at the Evercore ISI HealthCONx Conference,GlobeNewswire
Nov-30-18,Clementia Announces the Departure of Chief Commercial Officer,GlobeNewswire
Dec-11-18,What Type Of Shareholder Owns Clementia Pharmaceuticals Inc.s (NASDAQ:CMTA)?,Simply Wall St.
Feb-11-19,Clementia Granted Rare Pediatric Disease Designation by FDA for Palovarotene for Fibrodysplasia Ossificans Progressiva,GlobeNewswire
Feb-20-19,Clementia Announces Date of Fourth Quarter and Full Year 2018 Results and Presentation at 8th Annual SVB Leerink Global Healthcare Conference,GlobeNewswire
Feb-25-19,"Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Clementia Pharmaceuticals Inc. (CMTA) on Behalf of Stockholders and Encourages CMTA Investors to Contact the Firm",GlobeNewswire
Feb-25-19,Mario Gabelli's take on today's flurry of M&A activity,CNBC Videos
Feb-25-19,"Why Danaher, CRISPR Therapeutics, and Clementia Pharmaceuticals Jumped Today",Motley Fool
Feb-25-19,Here's Why Clementia Pharmaceuticals Rocketed Higher Today,Motley Fool
Feb-25-19,Trade tariff reprieve triggers relief in European shares,Reuters
